Verona Pharma American Depositary Share Return On Tangible Equity 2017-2025 | VRNA

Verona Pharma American Depositary Share return on tangible equity for the quarter ending March 31, 2025 was -90.11.

  • Verona Pharma American Depositary Share average return on tangible equity for 2024 was -64.22, a 187.34% increase from 2023.
  • Verona Pharma American Depositary Share average return on tangible equity for 2023 was -22.35, a 47.95% increase from 2022.
  • Verona Pharma American Depositary Share average return on tangible equity for 2022 was -42.94, a 2.98% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

Verona Pharma American Depositary Share Return On Tangible Equity 2017-2025 | VRNA

  • Verona Pharma American Depositary Share average return on tangible equity for 2024 was -64.22, a 187.34% increase from 2023.
  • Verona Pharma American Depositary Share average return on tangible equity for 2023 was -22.35, a 47.95% increase from 2022.
  • Verona Pharma American Depositary Share average return on tangible equity for 2022 was -42.94, a 2.98% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.